726 studies found for:    Open Studies | "Platelet Aggregation Inhibitors"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Platelet Aggregation Inhibitors"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown  Cost-effectiveness of Genotype Guided Treatment With Antiplatelet Drugs in STEMI Patients: Optimization of Treatment
Conditions: Myocardial Infarction;   STEMI
Intervention: Genetic: CYP2C19 genotyping
2 Recruiting Research of Resistance to Antiplatelet Agents and Development of Tailored Treatment Model for Patients With Coronary Artery Disease
Conditions: Cardiovascular Diseases;   Coronary Artery Disease
Intervention:
3 Recruiting The Laboratory AntiPlatelet Efficacy and Clinical Outcome Registry
Condition: Platelet Aggregation Onhibitors
Intervention: Drug: antiplatelet drugs - P2Y12 antagonists
4 Recruiting Atrial Fibrillation and Ischemic Events With Rivaroxaban in Patients With Stable Coronary Artery Disease Study
Condition: Atrial Fibrillation
Interventions: Drug: Rivaroxaban and single antiplatelet drug (aspirin, clopidogrel or prasugrel);   Drug: Rivaroxaban
5 Unknown  Study of LC23-1306 in Healthy Male Subjects
Condition: Acute Coronary Syndrome
Interventions: Drug: LC23-1306;   Drug: placebo;   Drug: Ticagrelor
6 Recruiting Bedside Testing of CYP2C19 Gene for Treatment of Patients With PCI With Antiplatelet Therapy
Conditions: Coronary Artery Disease;   Myocardial Infarction;   Heart Disease;   Vascular Disease;   Angina Pectoris;   Cardiovascular Disease;   Ischemia;   Infarction;   Embolism;   Thrombosis;   Chest Pain
Interventions: Drug: clopidogrel;   Drug: Ticagrelor or prasugrel
7 Not yet recruiting Pharmacokinetics of Antiplatelet Drugs in Diabetic pAtients
Condition: Diabetes
Intervention: Drug: Clopidogrel, Prasugrel, Ticagrelor
8 Unknown  Evaluation of Antiplatelet Drug Resistance in Taiwanese With VASP & Platelet Mapping ™ Assay
Condition: 30 Healthy People
Intervention: Drug: Clopidogrel and proton pump inhibitors
9 Recruiting Apixaban Versus Antiplatelet Drugs or no Antithrombotic Drugs After Anticoagulation-associated Intracerebral Haemorrhage in Patients With Atrial Fibrillation
Conditions: Cerebral Hemorrhage;   Atrial Fibrillation
Interventions: Drug: Apixaban;   Drug: Aspirin;   Drug: Carbasalate calcium;   Drug: Clopidogrel;   Drug: Dipyridamole;   Other: No antithrombotic treatment
10 Recruiting Effect of Second-look Endoscopy on Peptic Ulcer Rebleeding in Patients With Early Resumption of Antiplatelet Agents
Conditions: OGD;   Gastric Ulcer Induced by Anti-platelet Agent;   Duodenal Ulcer Induced by Anti-platelet Agent
Interventions: Procedure: Second-look OGD;   Drug: Esomeprazole
11 Unknown  rFVIIa in ICH in Patients Treated With Anticoagulants or Anti-Platelets
Condition: Intracerebral Hemorrhage
Interventions: Drug: rFVIIa + (vit K in AO patients);   Drug: FFP or aPCC+ vit K in AO treated patients
12 Recruiting Antithrombotic Strategy Variability In ATrial Fibrillation and Obstructive Coronary Disease Revascularized With PCI - The AVIATOR 2 Registry
Condition: Non-valvular Atrial Fibrillation
Intervention:
13 Not yet recruiting Secondary Prevention of Cardiovascular Disease in the Elderly Trial
Conditions: Myocardial Infarction;   Cardiovascular Disease
Interventions: Drug: Cardiovascular Polypill;   Drug: Treatment Prevention for Secondary CV
14 Recruiting A Randomized Controlled Trial of TNK-tPA Versus Standard of Care for Minor Ischemic Stroke With Proven Occlusion
Condition: Stroke, Acute
Interventions: Drug: Tenecteplase;   Drug: Antiplatelet treatment
15 Recruiting Impact of Anticoagulants and Antiplatelets in Patients on Transurethral Resection of the Prostate
Conditions: Benign Prostatic Hyperplasia;   Prostate Cancer
Intervention:
16 Recruiting What is the Optimal antiplatElet and Anticoagulant Therapy in Patients With Oral Anticoagulation Undergoing revasculariSaTion 2.
Conditions: Atrial Fibrillations;   Heart Valve Prostheses;   Acute Coronary Syndromes;   Coronary Artery Diseases;   Stroke;   Bleeding;   Myocardial Infarction
Intervention: Drug: Combination of chronic oral anticoagulation and a P2Y12 inhibitor with or without aspirin.
17 Recruiting ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-2 Study
Condition: Coronary Artery Disease
Interventions: Drug: 1-month DAPT;   Drug: 12-month DAPT
18 Recruiting Safety of PZ-128 in Subjects Undergoing Non-Emergent Percutaneous Coronary Intervention
Conditions: Arterial Occlusive Diseases;   Coronary Artery Disease;   Coronary Disease;   Arteriosclerosis;   Heart Diseases;   Myocardial Ischemia;   Vascular Diseases;   Acute Coronary Syndrome
Interventions: Drug: PZ-128;   Drug: Placebo
19 Recruiting Antiplatelet Therapy for Patients Undergoing Transcatheter Aortic Valve Implantation
Conditions: Aortic Valve Disease;   Myocardial Infarction;   Stroke;   Bleeding
Interventions: Drug: Aspirin + clopidogrel;   Drug: Aspirin monotherapy;   Drug: OAC + clopicogrel;   Drug: OAC monotherapy
20 Recruiting Resveratrol and First-degree Relatives of Type 2 Diabetic Patients
Condition: Pre-diabetes
Interventions: Dietary Supplement: placebo;   Dietary Supplement: resveratrol

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years